Human Rotavirus Vaccine from Japan
A live attenuated oral vaccine containing reassortant rotaviruses for active immunization against rotavirus gastroenteritis in infants. Classified under HTS 3002.49.0050 as it is a vaccine for human use, other than those specifically enumerated elsewhere in heading 3002. It is prepared for prophylactic purposes via biotechnological processes.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Obtain FDA import permit and biologics license; maintain cold chain documentation throughout transit to preserve efficacy
• Declare exact strain and dosage form; provide lot release certificates from manufacturer to avoid holds